Variant report
Variant | esv1797162 |
---|---|
Chromosome Location | chr5:92972389-92989773 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:92987752..92989863-chr5:92996146..92998098,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6556828 | chr5:92972389-92972390 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs540163493 | chr5:92972395-92972396 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs527868274 | chr5:92972446-92972447 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs7733506 | chr5:92972504-92972505 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs7714009 | chr5:92972522-92972523 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs533249441 | chr5:92972534-92972535 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs7737673 | chr5:92972623-92972624 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs546944431 | chr5:92972646-92972647 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs566795670 | chr5:92972649-92972650 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs7714282 | chr5:92972667-92972668 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs191571908 | chr5:92972689-92972690 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs139191772 | chr5:92972739-92972740 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs568459103 | chr5:92972745-92972746 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs141410368 | chr5:92972746-92972747 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs556919207 | chr5:92972778-92972779 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs184447398 | chr5:92972791-92972792 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs539468550 | chr5:92972816-92972817 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs553215204 | chr5:92972884-92972885 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs573493059 | chr5:92972934-92972935 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs190560342 | chr5:92973022-92973023 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs76693385 | chr5:92973059-92973060 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs570664683 | chr5:92973061-92973062 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs61134110 | chr5:92973078-92973079 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs386404460 | chr5:92973080-92973081 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs57017125 | chr5:92973081-92973082 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs75584022 | chr5:92973082-92973083 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs78797548 | chr5:92973091-92973092 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs77681502 | chr5:92973092-92973093 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs562356479 | chr5:92973172-92973173 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs561981207 | chr5:92973209-92973210 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs182215845 | chr5:92973226-92973227 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs544328565 | chr5:92973287-92973288 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs564049942 | chr5:92973362-92973363 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs75007012 | chr5:92973436-92973437 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs185217740 | chr5:92973473-92973474 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs560439910 | chr5:92973601-92973602 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs316927 | chr5:92973637-92973638 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs79981550 | chr5:92973651-92973652 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs150831767 | chr5:92973663-92973664 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs569068347 | chr5:92973682-92973683 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs537125201 | chr5:92973709-92973710 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs7442789 | chr5:92973726-92973727 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs375328562 | chr5:92973845-92973846 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs138312285 | chr5:92973868-92973869 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs114212133 | chr5:92973984-92973985 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs539406027 | chr5:92974006-92974007 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs188811923 | chr5:92974097-92974098 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs181270999 | chr5:92974101-92974102 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs536188138 | chr5:92974125-92974126 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs555666408 | chr5:92974149-92974150 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Mental retardation | 19471318 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:92961400-93007000 | Weak transcription | Primary T cells from cord blood | blood |
2 | chr5:92965200-92985400 | Weak transcription | Primary B cells from cord blood | blood |
3 | chr5:92971400-92973600 | Weak transcription | HepG2 | liver |
4 | chr5:92971600-92972600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr5:92971600-92973000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
6 | chr5:92972000-92973000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
7 | chr5:92972600-92972800 | Enhancers | Primary hematopoietic stem cells | blood |
8 | chr5:92972600-92973000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
9 | chr5:92973000-92973400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
10 | chr5:92973200-92974400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr5:92973400-92974400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
12 | chr5:92973600-92974000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr5:92973600-92974000 | Enhancers | HepG2 | liver |
14 | chr5:92977800-92979200 | Enhancers | Placenta | Placenta |
15 | chr5:92980200-92981000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr5:92981000-92981200 | Enhancers | Placenta | Placenta |
17 | chr5:92982600-92983200 | Enhancers | Adipose Nuclei | Adipose |
18 | chr5:92987000-93015400 | Weak transcription | Primary hematopoietic stem cells | blood |